Approaches to therapy for depressions in neurology: prospects for the use of agomelatine
This review provides information on prospects for using the antidepressant agomelatine in neurological practice. The drug has a unique receptor profile, being a melatonin receptor type 1 and 2 agonist and a serotonin receptor subtype 2C antagonist. Due to this and in addition to antidepressant actio...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2018-12-01
|
Series: | Nevrologiâ, Nejropsihiatriâ, Psihosomatika |
Subjects: | |
Online Access: | https://nnp.ima-press.net/nnp/article/view/1004 |